AU495840B2 - - Google Patents

Info

Publication number
AU495840B2
AU495840B2 AU65910/74A AU6591074A AU495840B2 AU 495840 B2 AU495840 B2 AU 495840B2 AU 65910/74 A AU65910/74 A AU 65910/74A AU 6591074 A AU6591074 A AU 6591074A AU 495840 B2 AU495840 B2 AU 495840B2
Authority
AU
Australia
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
AU65910/74A
Other languages
English (en)
Other versions
AU6591074A (en
Publication of AU495840B2 publication Critical patent/AU495840B2/en
Priority claimed from GB914973A external-priority patent/GB1476422A/en
Application filed filed Critical
Publication of AU6591074A publication Critical patent/AU6591074A/en
Expired legal-status Critical Current

Links

AU65910/74A 1973-02-23 1974-02-22 Glycoprotein from bacteria Expired AU6591074A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB914973A GB1476422A (en) 1973-02-23 1973-02-23 Biological extracts

Publications (2)

Publication Number Publication Date
AU495840B2 true AU495840B2 (enExample)
AU6591074A AU6591074A (en) 1975-08-28

Family

ID=9866339

Family Applications (1)

Application Number Title Priority Date Filing Date
AU65910/74A Expired AU6591074A (en) 1973-02-23 1974-02-22 Glycoprotein from bacteria

Country Status (12)

Country Link
JP (1) JPS5063196A (enExample)
AU (1) AU6591074A (enExample)
BE (1) BE811491A (enExample)
DE (1) DE2408724A1 (enExample)
DK (1) DK141757B (enExample)
FR (1) FR2218888B1 (enExample)
GB (1) GB1476422A (enExample)
HU (1) HU173676B (enExample)
IE (1) IE39332B1 (enExample)
IL (1) IL44267A (enExample)
NL (1) NL7402455A (enExample)
ZA (1) ZA741189B (enExample)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2410476B1 (fr) * 1977-11-30 1980-08-22 Inst Nat Sante Rech Med Application des peptidoglycanes extraits de bacteries, en particulier des bacillus a titre de medicaments, notamment stimulant l'immunite antitumorale
JPS58874B2 (ja) * 1979-08-30 1983-01-08 株式会社 目黒研究所 糖蛋白wenac及びその製造法
FR2502496A2 (fr) * 1981-03-30 1982-10-01 Pasteur Institut Fractions nouvelles extraites de bacteries aerobies, douees de proprietes antitumorales, antibacteriennes et inductrices d'interferon, et leur procede de preparation
US4479935A (en) * 1980-04-22 1984-10-30 Institut Pasteur Fractions extracted from aerobic bacteria, endowed with antitumoral, antibacterial and interferon inducing properties, and process for their preparation
FR2480604A1 (fr) * 1980-04-22 1981-10-23 Pasteur Institut Fractions nouvelles extraites de bacteries aerobies, douees de proprietes antitumorales, antibacteriennes et inductrices d'interferon et leur procede de preparation
US4871488A (en) * 1985-04-22 1989-10-03 Albany Medical College Of Union University Reconstituting viral glycoproteins into large phospholipid vesicles
LT3049430T (lt) * 2014-07-16 2019-04-10 Depofarma S.P.A. Propionibacterium granulosum parietalinė frakcija, atliekanti imunomoduliacinius veiksmus

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3450815A (en) * 1964-04-24 1969-06-17 Princeton Lab Inc Method of stimulating a host defense mechanism with an actinovaccine
US3529057A (en) * 1964-08-14 1970-09-15 Takeda Chemical Industries Ltd Purified periodic acid-oxidized mucopeptide of mycobacteria cell walls constituting a vaccine enhancing nonspecific host resistance against pathogenic bacterial infections

Similar Documents

Publication Publication Date Title
US10576109B2 (en) Propionibacterium acnes and granulosum parietal fraction having immunomodulating action
EP0024941B1 (en) Water-soluble extract from nonpathogenic aerobic corynebacteria, production thereof and compositions containing the extract
AU495840B2 (enExample)
FR2218888B1 (enExample)
FR2410476B1 (fr) Application des peptidoglycanes extraits de bacteries, en particulier des bacillus a titre de medicaments, notamment stimulant l'immunite antitumorale
FR2502496B2 (enExample)